The Study of Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgFUS) Treatment for Adenomyosis

This study evaluated the safety and efficacy of magnetic resonance-guided high-intensity focused ultrasound (MRgFUS) for uterine adenomyosis in 62 patients, monitoring adverse reactions during treatment and assessing changes in uterine size and dysmenorrhea scores pre- versus post-treatment. The authors report that all 62 patients completed MRgFUS successfully without severe adverse reactions, with an average ablation rate of 69.12% ± 17.64%. After treatment, uterine volume and dysmenorrhea scores improved significantly compared with baseline (p < 0.05). The paper is presented as an abstract and does not specify additional limitations such as study design details beyond the safety/efficacy observations. This paper is centrally about adenomyosis — it investigates MRgFUS as a non-invasive treatment for adenomyosis-related dysmenorrhea and uterine changes.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works